Researchers at the Medical College of Georgia at Augusta University are searching for a better way to understand why many men with prostate cancer end up with Alzheimer’s disease, and whether it’s the standard hormone therapy treatment or an overactive immune response that actually contributes to the problem.
APONTIS PHARMA and Zentiva enter into investment agreement – Zentiva will launch a voluntary public purchase offer – Biotech Investments
APONTIS PHARMA AG / Key word(s): Tender Offer APONTIS PHARMA and Zentiva enter into investment agreement – Zentiva will launch a voluntary public purchase offer
October 17, 2024